文献
J-GLOBAL ID:201102276492093225
整理番号:11A1220682
全身性エリテマトーデスにおけるトシリズマブ:非盲検第I相用量増加研究から得られた安全性,予備的有効性,循環血中形質細胞に及ぼす影響に関するデータ
Tocilizumab in Systemic Lupus Erythematosus Data on Safety, Preliminary Efficacy, and Impact on Circulating Plasma Cells From an Open-Label Phase I Dosage-Escalation Study
著者 (11件):
ILLEI Gabor G.
(National Inst. Of Arthritis And Musculoskeletal And Skin Diseases)
,
SHIROTA Yuko
(National Inst. Of Arthritis And Musculoskeletal And Skin Diseases)
,
YARBORO Cheryl H.
(National Inst. Of Arthritis And Musculoskeletal And Skin Diseases)
,
DARUWALLA Jimmy
(National Inst. Of Arthritis And Musculoskeletal And Skin Diseases)
,
TACKEY Edward
(National Inst. Of Arthritis And Musculoskeletal And Skin Diseases)
,
TAKADA Kazuki
(National Inst. Of Arthritis And Musculoskeletal And Skin Diseases)
,
LIPSKY Peter E.
(National Inst. Of Arthritis And Musculoskeletal And Skin Diseases)
,
ILLEI Gabor G.
(National Inst. Of Dental And Craniofacial Res.)
,
SHIROTA Yuko
(National Inst. Of Dental And Craniofacial Res.)
,
FLEISHER Thomas
(Clinical Center, NIH)
,
BALOW James E.
(National Inst. Of Diabetes And Digestive And Kidney Diseases, NIH, Maryland)
資料名:
Arthritis & Rheumatism
(Arthritis & Rheumatism)
巻:
62
号:
2
ページ:
542-552
発行年:
2010年02月
JST資料番号:
C0784B
ISSN:
0004-3591
資料種別:
逐次刊行物 (A)
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)